ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Electronic Hauser Diary For Parkinson's Clinical Trials

  In honor of World Movement Disorders Day, we highlight advances in Parkinson’s disease care. At the 2024 MDS Congress, Signant presented research on electronic diaries for tracking PD patients' functional status.

• Site And Sponsor Harmonization For Speedy Startups, Monitoring

  Now more than ever, stakeholders need harmony among their disparate systems — and that starts with the right organizational mindset: a culture of connectivity. Here’s what our experts recommend.

• Enhancing Oncology Trials With Clinical Platform Solutions

  This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.

• Unlocking The Value Of AI In IRT: Practical Perspectives From Vendors

  AI can enhance IRT with predictive modeling and automation, but true success relies on high-quality data, compliance, and user trust. Learn practical strategies to boost efficiency.

• Demystifying AI: The Fundamentals And Applications In Drug Development

  Explore the history of AI, gain clarity on key concepts, address common questions, and discover its transformative role in drug development, with insights into its current and future impact on the industry.

• Crowdsource UAT: An Opportunity For Future Validation

  IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.

• 5 Key Takeaways From The FDA's Real-World Evidence Guidance

  With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

• Digital/Hybrid Trials Deliver Greater ROI Than Traditional Trials

  In this paper, Tufts CSDD outlines why and how modernized clinical trials can drive greater savings (up to $40,000,000 per study) than traditional trials.

• The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials

  Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

• From Buzzword To Backbone: AI Reshaping Clinical Trial Operations

  For teams evaluating how to accelerate study startup without sacrificing rigor, this is a clear look at what AI-native trial technology makes possible now.